Novo Capital (formerly MSA Novo) is a multi-stage global venture capital firm and Singapore-based franchise of MSA Capital, investing in technology-focused startups across emerging markets including LATAM, Africa, MENA, India, and Southeast Asia.
48% of their portfolio is in Biotech & Life Sciences. Average disclosed round size is $93.7M (across 165 rounds with reported amounts).
Portfolio
151
Fund Size
—
Top Stage
Series A
Last 12 Mo
14
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
225 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 OMass Therapeutics | Series C | $310M | Oct 2026 |
 AnaCardio | Series B | — | Sep 2026 |
 Crystalys | Series A | $205M | Sep 2026 |
| PPrecirix | Series B | — | Aug 2026 |
 cAMPfield Therapeutics | Series A | $180M | Jun 2026 |
| CcAMPfield | Series A | $180M | Jun 2026 |
 Windward | Unknown | $165M | May 2026 |
 Ray Therapeutics | Series B | $125M | Apr 2026 |
 Terremoto Biosciences | Series C | $108M | Apr 2026 |
 Adcendo ApS | Series C | $75M | Apr 2026 |
 Route 92 Medical | Growth | $50M | Apr 2026 |
 Tribune Therapeutics | Series A | — | Jan 2026 |
| CClaris Bio | Series B | $57M | Jan 2026 |
 Claris | Series B | $118M | Jan 2026 |
| cAMPfield Therapeutics | Series A | $180M | Jan 2026 |
 Chromologics | Unknown | — | Nov 2025 |
| HHemab | Series C | $157M | Oct 2025 |
 MATR Foods | Series A | — | Oct 2025 |
 MapLight Therapeutics | Series D | $372.5M | Jul 2025 |
 GlycoEra | Series B | $130M | May 2025 |
| Tribune Therapeutics | Series A | — | Apr 2025 |
 Augustine Therapeutics | Series A | — | Mar 2025 |
 Reneo | Series B | $47.3M | Feb 2025 |
| NNumab Therapeutics | Series C | $55M | Jan 2025 |
 Coave Therapeutics | Series A | $33M | Jan 2025 |
Page 1 of 9
Top Co-Investors
Novo Holdings A/S98 shared
Sofinnova Partners35 shared
OrbiMed29 shared
RA Capital Management24 shared
Rock Springs Capital20 shared
Forbion19 shared
Cormorant Asset Management17 shared
Sanofi Ventures15 shared
Longitude Capital14 shared
Gilde Healthcare13 shared
HealthCap13 shared
Vivo Capital13 shared
EIFO13 shared
Jeito Capital12 shared
RiverVest Venture Partners12 shared
New Enterprise Associates12 shared
Pontifax12 shared
SR One11 shared
Catalio Capital Management11 shared
Pivotal Life Sciences11 shared
Last updated: 20 October 2026